Global Information
회사소개 | 문의 | 비교리스트

세계의 멀티플렉스 어세이 시장 예측(-2026년) : 제품(소모품, 장비, 소프트웨어와 서비스), 종류(핵산, 단백질, 세포), 기술(유세포 분석, 발광), 용도(R&D, 진단), 최종사용자(제약과 바이오테크놀러지, 병원)별

Multiplex Assays Market by product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence, Application(R&D, Diagnosis), End User(Pharma & Biotech, Hospital) - Global Forecast -2026

리서치사 MarketsandMarkets
발행일 2021년 12월 상품코드 1043612
페이지 정보 영문 257 Pages 배송안내
가격
US $ 4,950 ₩ 6,307,000 PDF (Single User License) help
1명만 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 6,650 ₩ 8,473,000 PDF (5-user License) help
동일 사업장 내 5명까지 공유하여 이용할 수 있는 라이선스입니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 8,150 ₩ 10,384,000 PDF (Corporate License) help
기업 내 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없지만, 동일 국가의 동일 사업장에 한정되며 해외지점 등은 포함되지 않습니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.
US $ 10,000 ₩ 12,742,000 PDF (Global License) help
동일 기업의 모든 분들이 이용할 수 있는 라이선스입니다. 이용 인원수에 제한은 없습니다. 100% 자회사는 동일 기업으로 간주됩니다. PDF 파일은 Copy & Paste가 가능합니다. 인쇄횟수에 제한은 없으나, 인쇄물의 이용 범위는 PDF 이용 범위에 준합니다.


세계의 멀티플렉스 어세이 시장 예측(-2026년) : 제품(소모품, 장비, 소프트웨어와 서비스), 종류(핵산, 단백질, 세포), 기술(유세포 분석, 발광), 용도(R&D, 진단), 최종사용자(제약과 바이오테크놀러지, 병원)별 Multiplex Assays Market by product (Consumables, Instruments, Software & Services), Type (Nucleic Acid, Protein, Cell), Technology (Flow Cytometry, Luminescence, Application(R&D, Diagnosis), End User(Pharma & Biotech, Hospital) - Global Forecast -2026
발행일 : 2021년 12월 페이지 정보 : 영문 257 Pages

본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

세계의 멀티플렉스 어세이 시장 규모는 2021년 30억 달러에서 예측기간 중 7.6%의 CAGR로 확대되고, 2026년에는 43억 달러 규모로 성장할 것으로 예측됩니다.

시장 성장의 주요 요인은 동반진단 도입 확대, 만성질환이나 감염증 발생률 상승, 질환 진단에 대한 의식 향상, 연구나 임상 진단에서 운영 비용이나 진단에 걸리는 시간을 단축하기 위한 효과적인 분석 플랫폼이 요구되고 있는 점 등입니다. 한편 멀티플렉스 어세이 기기의 고비용성, 엄격한 규제나 기준, 멀티플렉스 어세이 디자인의 표준화 문제 등이 시장 성장을 저해하는 큰 요인이 되고 있습니다.

제품 및 서비스별로는 소모품 부문이 2020년에 최대의 점유율을 나타내고, 또한 최대의 성장을 나타내고 있습니다. 이것은 연구 용도 확대에 따라 어세이나 시약을 반복 구입하는 것이 원인으로 생각됩니다. 또한 종류별로는 단백질 기반 멀티플렉스 어세이 부문이 최대의 점유율을 나타내고, 예측기간 중에도 최대의 CAGR로 성장할 것으로 예측됩니다. 이 큰 점유율은 바이오마커 연구나 임상 진단을 위해 프로테오믹스 연구가 주목받고 있는 점에 기인하고 있습니다.

세계의 멀티플렉스 어세이(Multiplex Assays) 시장을 조사했으며, 시장 정의와 개요, 시장 영향요인 분석, 시장 규모 추정과 예측, 제품 및 서비스·종류·기술·용도·최종사용자·지역/주요 국가 등 각종 세분화별 내역, 경쟁 상황, 주요 기업 개요 등을 정리했습니다.

목차

제1장 서론

제2장 조사 방법

제3장 주요 요약

제4장 주요 인사이트

제5장 시장 개요

  • 시장 역학
    • 성장 촉진요인
    • 성장 억제요인
    • 시장 기회
    • 과제

제6장 멀티플렉스 어세이 시장 : 제품 및 서비스별

  • 소모품
  • 기기
  • 소프트웨어와 서비스

제7장 멀티플렉스 어세이 시장 : 종류별

  • 단백질 멀티플렉스 어세이
    • 평면 단백질 어세이
    • 비즈 기반 단백질 어세이
    • 기타
  • 핵산 멀티플렉스 어세이
    • 평면 핵산 어세이
    • 비즈 기반 핵산 어세이
    • 기타
  • 세포 기반 멀티플렉스 어세이

제8장 멀티플렉스 어세이 시장 : 기술별

  • 유세포 분석
  • 형광 검출
  • 발광
  • 멀티플렉스 실시간 PCR
  • 기타

제9장 멀티플렉스 어세이 시장 : 용도별

  • R&D
    • Drug Discovery & Development
    • 바이오마커 발견·검증
  • 임상 진단
    • 감염증
    • 심혈관질환
    • 자가면역질환
    • 신경계 장애
    • 대사 및 내분비 장애
    • 기타

제10장 멀티플렉스 어세이 시장 : 최종사용자별

  • 제약·바이오 기술 기업
  • 병원·연구기관
  • 표준실험실
  • 기타

제11장 멀티플렉스 어세이 시장 : 지역별

  • 북미
  • 유럽
  • 아시아태평양
  • 기타 지역

제12장 경쟁 상황

  • 개요
  • 주요 기업의 전략
  • 시장 순위 분석
  • 기업 평가 쿼드런트 : 주요 기업
  • 기업 평가 쿼드런트 : SME/스타트업
  • 경쟁 상황과 동향

제13장 기업 개요

  • ILLUMINA, INC.
  • LUMINEX CORPORATION
  • THERMO FISHER SCIENTIFIC INC.
  • BIO-RAD LABORATORIES, INC.
  • BECTON DICKINSON AND COMPANY
  • QIAGEN N.V.
  • ABCAM PLC
  • MERCK KGAA
  • AGILENT TECHNOLOGIES INC.
  • QUANTERIX
  • DIASORIN S.P.A.
  • BIO-TECHNE CORPORATION
  • MESO SCALE DIAGNOSTICS, LLC
  • RANDOX LABORATORIES LTD.
  • OLINK
  • 기타 기업
    • SEEGENE INC.
    • PROMEGA CORPORATION
    • SIEMENS HEALTHINEERS
    • PERKINELMER INC.
    • SHIMADZU CORPORATION
    • ANTIGENIX AMERICA, INC.
    • ENZO LIFE SCIENCES, INC.
    • CAYMAN CHEMICAL LTD.
    • BOSTER BIOLOGICAL TECHNOLOGY

제14장 부록

KSM 22.01.17

The global Multiplex Assays Market is projected to reach USD 4.3 billion by 2026 from USD 3.0 billion in 2021, at a CAGR of 7.6% during the forecast period. Market growth is mainly driven by factors such as the increasing adoption of companion diagnostics, the increasing incidence of chronic and infectious diseases, the growing awareness of the disease diagnosis, and the need for effective analytical platforms in research and clinical diagnostics to reduce the operational costs and the time taken for diagnosis. However, the high cost of multiplex assay equipment, stringent regulations and standards, and issues in the standardization of multiplex assays design are the major factors restraining the growth of this market.

"Product and Service accounted for the largest share of the Multiplex Assays Market and is expected to grow at the highest CAGR in the forecast period."

Based on product & service, the multiplex assays market is segmented into instruments, consumables, and software & services. In 2020, the consumables segment is expected to account for the largest share of the market; it is also the fastest-growing segment of the multiplex assays market. This can be attributed to the recurring purchase of assays and reagents for increasing research applications.

"Protein-based multiplex assays segment is expected to account for the largest share of the global multiplex assays market and is expected to grow at the highest CAGR in the forecast period."

Based on type, the global multiplex assays market is divided into protein-based multiplex assays, nucleic acid-based multiplex assays, and cell-based multiplex assays. In 2020, the protein-based multiplex assays segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increasing focus on proteomics studies for biomarker research and clinical diagnostics.

"Flow cytometry segment is expected to account for the largest share of the global multiplex assays market and is expected to grow at the highest CAGR in the forecast period."

On the basis of technology, the global multiplex assays market is divided into flow cytometry, multiplex RT PCR, luminescence, fluorescence detection, and other technologies. In 2020, the flow cytometry segment is expected to account for the largest share of the global multiplex assays market. The large share can be attributed to the wide applications of flow cytometry in the detection and measurement of protein expression, RNA, and cell health status (cell viability & toxicity) alongside the characterization and identification of various cell types.

"Research & development companies account for the largest share of the Multiplex Assays Market in 2020 and is expected to grow at the fastest CAGR in the forecast period."

On the basis of application, the global multiplex assays market is divided into research & development and clinical diagnostics. In 2020, the research & development segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the wide applications of multiplex assay technologies in research & development functions.

"Pharmaceutical & biotechnology companies account for the largest share of the Multiplex Assays Market in 2020 and is expected to grow at the fastest CAGR in the forecast period."

Based on end user, the multiplex assays market is segmented into pharmaceutical & biotechnology companies, hospitals & research institutes, reference laboratories and other end users. In 2020, the pharmaceutical & biotechnology companies segment is expected to account for the largest share of the global multiplex assays market. This large share can be attributed to the increasing adoption of multiplex assays in drug discovery and development by pharmaceuticals and the growing focus of biotechnology companies on developing biosimilars and monoclonal antibodies.

"North America will dominate the market during the forecast period."

Geographically, the Multiplex Assays Market is segmented into four major regions, namely, North America (US and Canada), Europe, Asia Pacific, and Rest of the world. North America was the largest regional market for Multiplex Assays Market in 2020. North America is expected to account for the largest share of the multiplex assays market in 2020, followed by Europe. The dominant share of the North American market is primarily attributed to its established pharmaceutical industry, presence of leading pharmaceutical and biotechnology companies, and high R&D investment.

The primary interviews conducted for this report can be categorized as follows:

  • By Company Type - Tier 1: 42%, Tier 2: 37%, and Tier 3: 21%
  • By Designation - C-level: 34%, D-level: 42%, and Others: 23%
  • By Region - North America: 32%, Europe: 30%, Asia Pacific: 24%, and Rest of the World: 14%

List of Companies Profiled in the Report

  • Luminex Corporation (US)
  • Thermo Fisher Scientific Inc. (US)
  • Illumina, Inc (US)
  • Bio-Rad Laboratories, Inc. (US)
  • Qiagen N.V. (Netherlands)
  • Abcam plc (UK)
  • Becton, Dickinson and Company (US)
  • Merck KGaA (Germany)
  • Agilent Technologies, Inc. (US)
  • Meso Scale Diagnostics (US)
  • Randox Laboratories (UK)
  • Quanterix (US)
  • Bio-Techne Corporation (US)
  • Olink (Sweden)
  • DiaSorin S.p.A. (Italy)
  • Seegene (South Korea)
  • Promega Corporation (US)
  • Siemens Healthineers (Germany)
  • PerkinElmer, Inc. (US)
  • Shimadzu Biotech (Japan)
  • Antigenix America, Inc. (US)
  • Enzo Life Sciences, Inc. (US)
  • Boster Biological Technology (US)
  • AYOXXA Biosystems GmbH (Germany)
  • Cayman Chemical Company (US).

Research Coverage:

This report provides a detailed picture of the global multiplex assays market. It aims at estimating the size and future growth potential of the market across different segments, such as type, end user and region. The report also analyzes factors (such as drivers, restraints, opportunities and challenges) affecting market growth. It evaluates the opportunities in the market for stakeholders and provides details of the competitive landscape for market leaders. The report also studies micromarkets with respect to their growth trends, prospects, and contributions to the total multiplex assays market. The report forecasts the revenue of the market segments with respect to four major regions.

Reasons to Buy the Report:

The report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on multiplex assays offered by the top 15 players in the multiplex assays market. The report analyses the multiplex assays market by product & service, type, technology, application, end user, and region
  • Market Development: Comprehensive information about lucrative emerging markets. The report analyses the markets for various multiplex assays across key geographic regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the multiplex assays market.
  • Competitive Assessment: In-depth assessment of market ranking and strategies of the leading players in the multiplex assays market.

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 OBJECTIVES OF THE STUDY
  • 1.2 MARKET DEFINITION
    • TABLE 1 INCLUSIONS & EXCLUSIONS OF THE STUDY
  • 1.3 MARKET SCOPE
    • 1.3.1 MARKETS COVERED
    • 1.3.2 YEARS CONSIDERED FOR THE STUDY
  • 1.4 CURRENCY
    • TABLE 2 EXCHANGE RATES UTILIZED FOR THE CONVERSION TO USD
  • 1.5 STAKEHOLDERS
  • 1.6 LIMITATIONS

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 MULTIPLEX ASSAYS MARKET: RESEARCH DESIGN
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Key data from secondary sources
  • 2.2 PRIMARY DATA
    • 2.2.1 KEY DATA FROM PRIMARY SOURCES
      • 2.2.1.1 Key data from primary sources
      • 2.2.1.2 Key industry insights
    • FIGURE 2 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
  • 2.3 MARKET SIZE ESTIMATION
    • FIGURE 3 MULTIPLEX ASSAYS MARKET - REVENUE SHARE ANALYSIS ILLUSTRATION: ILLUMINA, INC.
    • FIGURE 4 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH (SUPPLY SIDE): COLLECTIVE REVENUE OF MULTIPLEX ASSAY PRODUCTS
    • FIGURE 5 CAGR PROJECTIONS
    • FIGURE 6 TOP-DOWN APPROACH
  • 2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
    • 2.4.1 SECONDARY DATA
    • 2.4.2 PRIMARY DATA
  • 2.5 DATA TRIANGULATION METHODOLOGY
    • FIGURE 7 DATA TRIANGULATION
  • 2.6 MARKET SHARE ANALYSIS
  • 2.7 ASSUMPTIONS FOR THE STUDY
  • 2.8 INDICATORS AND ASSUMPTIONS AND THEIR IMPACT ON THE STUDY
    • 2.8.1 COVID-19-SPECIFIC ASSUMPTIONS
  • 2.9 LIMITATIONS
  • 2.10 RISK ASSESSMENT
    • TABLE 3 RISK ASSESSMENT
  • 2.11 COVID-19 HEALTH ASSESSMENT
  • 2.12 COVID-19 ECONOMIC ASSESSMENT
  • 2.13 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE ECONOMIC SCENARIO
    • FIGURE 8 CRITERIA IMPACTING THE GLOBAL ECONOMY
    • FIGURE 9 RECOVERY SCENARIO OF THE GLOBAL ECONOMY
  • 2.14 ASSESSMENT OF THE IMPACT OF COVID-19 ON THE MULTIPLEX ASSAYS MARKET

3 EXECUTIVE SUMMARY

    • FIGURE 10 MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021 VS. 2026 (USD BILLION)
    • FIGURE 11 MULTIPLEX ASSAYS MARKET, BY TYPE, 2021 VS. 2026 (USD BILLION )
    • FIGURE 12 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021 VS. 2026 (USD BILLION)
    • FIGURE 13 MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021 VS. 2026 (USD BILLION )
    • FIGURE 14 MULTIPLEX ASSAYS MARKET, BY END USER, 2021 VS. 2026 (USD BILLION)
    • FIGURE 15 GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET (2021-2026)

4 PREMIUM INSIGHTS

  • 4.1 MULTIPLEX ASSAYS MARKET OVERVIEW
    • FIGURE 16 INCREASING ADOPTION OF MULTIPLEX ASSAYS IN COMPANION DIAGNOSTICS TO DRIVE THE MARKET GROWTH
  • 4.2 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION AND COUNTRY (2020)
    • FIGURE 17 R&D TO ACCOUNT FOR THE LARGEST SHARE OF THE NORTH AMERICAN MULTIPLEX ASSAYS MARKET IN 2020
  • 4.3 MULTIPLEX ASSAYS MARKET, BY REGION (2021 VS. 2026)
    • FIGURE 18 NORTH AMERICA TO DOMINATE THE MULTIPLEX ASSAYS MARKET IN 2026
  • 4.4 GEOGRAPHICAL SNAPSHOT OF THE MULTIPLEX ASSAYS MARKET
    • FIGURE 19 APAC TO BE THE FASTEST-GROWING MARKET FROM 2021 TO 2026

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 GLOBAL MULTIPLEX ASSAYS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 Increasing use of multiplex assays in companion diagnostics
      • 5.2.1.2 Increasing advantages over singleplex and traditional assays
      • 5.2.1.3 Increasing incidence of chronic and infectious diseases and growing awareness about early disease diagnosis
    • FIGURE 21 INCIDENCE OF DIABETES, BY REGION, 2019, 2030, AND 2045
    • TABLE 4 GLOBAL INCIDENCE OF INFECTIOUS DISEASES
    • TABLE 5 APPROVED AND LAUNCHED MULTIPLEX ASSAYS FOR THE DIAGNOSIS OF SARS-COV-2
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Increasing costs of equipment
      • 5.2.2.2 Growing number of stringent regulations and standards
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Increasing validation of biomarkers in molecular and protein diagnostics
      • 5.2.3.2 Rising need for high-throughput and automated systems
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Increasing dearth of skilled professionals

6 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE

  • 6.1 INTRODUCTION
    • TABLE 6 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE, 2016-2020 (USD MILLION)
    • TABLE 7 MULTIPLEX ASSAYS MARKET, BY PRODUCT AND SERVICE, 2021-2026 (USD MILLION)
  • 6.2 CONSUMABLES
    • TABLE 8 MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 9 MULTIPLEX ASSAY CONSUMABLES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 10 NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 11 NORTH AMERICA: MULTIPLEX ASSAY CONSUMABLES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 12 MULTIPLEX ASSAY INSTRUMENTS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 13 MULTIPLEX ASSAY INSTRUMENT MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 14 NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 15 NORTH AMERICA: MULTIPLEX ASSAY INSTRUMENTS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 6.4 SOFTWARE & SERVICES
    • TABLE 16 MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 17 MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 18 NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 19 NORTH AMERICA: MULTIPLEX ASSAY SOFTWARE & SERVICES MARKET, BY COUNTRY, 2021-2026 (USD MILLION)

7 MULTIPLEX ASSAYS MARKET, BY TYPE

  • 7.1 INTRODUCTION
    • TABLE 20 MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 21 MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
  • 7.2 PROTEIN MULTIPLEX ASSAYS
    • TABLE 22 PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 23 PROTEIN MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 24 PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 25 PROTEIN MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026(USD MILLION)
    • TABLE 26 NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 27 NORTH AMERICA: PROTEIN MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.2.1 PLANAR PROTEIN ASSAYS
    • TABLE 28 PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 29 PLANAR PROTEIN ASSAYS MARKET, BY REGION, 2021-2026(USD MILLION)
    • TABLE 30 NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 31 NORTH AMERICA: PLANAR PROTEIN ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.2.2 BEAD-BASED PROTEIN ASSAYS
    • TABLE 32 BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 33 BEAD-BASED PROTEIN ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 34 NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 35 NORTH AMERICA: BEAD-BASED PROTEIN ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.2.3 OTHER PROTEIN ASSAYS
    • TABLE 36 OTHER PROTEIN ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 37 OTHER PROTEIN ASSAYS MARKET, BY REGION, 2021-2026(USD MILLION)
    • TABLE 38 NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 39 NORTH AMERICA: OTHER PROTEIN ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 7.3 NUCLEIC ACID MULTIPLEX ASSAYS
    • TABLE 40 SOME OF THE FDA AUTHORIZED MULTIPLEX ASSAYS AND INSTRUMENTS AUTHORIZED FOR THE SIMULTANEOUS DETECTION OF INFLUENZA VIRUSES AND SARS-COV-2
    • TABLE 41 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 42 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 43 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 44 NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 45 NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 46 NORTH AMERICA: NUCLEIC ACID MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.3.1 PLANAR NUCLEIC ACID ASSAYS
    • TABLE 47 PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 48 PLANAR NUCLEIC ACID ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 49 NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 50 NORTH AMERICA: PLANAR NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.3.2 BEAD-BASED NUCLEIC ACID ASSAYS
    • TABLE 51 BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 52 BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 53 NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 54 NORTH AMERICA: BEAD-BASED NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • 7.3.3 OTHER NUCLEIC ACID ASSAYS
    • TABLE 55 OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 56 OTHER NUCLEIC ACID ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 57 NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 58 NORTH AMERICA: OTHER NUCLEIC ACID ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
  • 7.4 CELL-BASED MULTIPLEX ASSAYS
    • TABLE 59 CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 60 CELL-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 61 NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 62 NORTH AMERICA: CELL-BASED MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)

8 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY

  • 8.1 INTRODUCTION
    • TABLE 63 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 64 MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
  • 8.2 FLOW CYTOMETRY
    • TABLE 65 MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 66 MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 67 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 68 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLOW CYTOMETRY, BY COUNTRY, 2021-2026 (USD MILLION)
  • 8.3 FLUORESCENCE DETECTION
    • TABLE 69 MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 70 MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 71 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 72 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR FLUORESCENCE DETECTION, BY COUNTRY, 2021-2026 (USD MILLION)
  • 8.4 LUMINESCENCE
    • TABLE 73 MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 74 MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 75 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 76 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR LUMINESCENCE, BY COUNTRY, 2021-2026 (USD MILLION)
  • 8.5 MULTIPLEX REAL-TIME PCR
    • TABLE 77 MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 78 MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 79 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 80 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR MULTIPLEX RT PCR, BY COUNTRY, 2021-2026 (USD MILLION)
  • 8.6 OTHER TECHNOLOGIES
    • TABLE 81 MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 82 MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 83 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 84 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER TECHNOLOGIES, BY COUNTRY, 2021-2026 (USD MILLION)

9 MULTIPLEX ASSAYS MARKET, BY APPLICATION

  • 9.1 INTRODUCTION
    • TABLE 85 MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 86 MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
  • 9.2 RESEARCH & DEVELOPMENT
    • TABLE 87 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 88 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 89 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 90 MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 91 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 92 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR RESEARCH & DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.2.1 DRUG DISCOVERY & DEVELOPMENT
    • TABLE 93 MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 94 MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 95 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 96 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR DRUG DISCOVERY & DEVELOPMENT, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.2.2 BIOMARKER DISCOVERY & VALIDATION
    • TABLE 97 MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 98 MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 99 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 100 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR BIOMARKER DISCOVERY & VALIDATION, BY COUNTRY, 2021-2026 (USD MILLION)
  • 9.3 CLINICAL DIAGNOSTICS
    • TABLE 101 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 102 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 103 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 104 MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 105 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 106 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CLINICAL DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.1 INFECTIOUS DISEASES
    • TABLE 107 MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 108 MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 109 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 110 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR INFECTIOUS DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.2 CANCER
    • TABLE 111 INCREASING INCIDENCE OF CANCER, BY REGION, 2020 VS. 2030 VS. 2040 (MILLION)
    • TABLE 112 MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 113 MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 114 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 115 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CANCER DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.3 CARDIOVASCULAR DISEASES
    • TABLE 116 MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 117 MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 118 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 119 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR CARDIOVASCULAR DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.4 AUTOIMMUNE DISEASES
    • TABLE 120 PREVALENCE OF SOME AUTOIMMUNE DISEASES
    • TABLE 121 MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 122 MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 123 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 124 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR AUTOIMMUNE DISEASE DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.5 NERVOUS SYSTEM DISORDERS
    • TABLE 125 MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 126 MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 127 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 128 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR NERVOUS SYSTEM DISORDER DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.6 METABOLISM & ENDOCRINOLOGY DISORDERS
    • TABLE 129 MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 130 MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 131 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 132 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR METABOLISM & ENDOCRINOLOGY DISORDER DIAGNOSTICS, BY COUNTRY, 2021-2026 (USD MILLION)
    • 9.3.7 OTHER DISEASES
    • TABLE 133 MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 134 MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 135 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 136 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER DISEASES, BY COUNTRY, 2021-2026 (USD MILLION)

10 MULTIPLEX ASSAYS MARKET, BY END USER

  • 10.1 INTRODUCTION
    • TABLE 137 MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 138 MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026(USD MILLION)
  • 10.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
    • TABLE 139 MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 140 MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 141 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 142 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021-2026 (USD MILLION)
  • 10.3 HOSPITALS & RESEARCH INSTITUTES
    • TABLE 143 MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 144 MULTIPLEX ASSAYS MARKET FOR HOSPITALS & RESEARCH INSTITUTES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 145 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 146 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR HOSPITAL & RESEARCH INSTITUTES, BY COUNTRY, 2021-2026 (USD MILLION)
  • 10.4 REFERENCE LABORATORIES
    • TABLE 147 MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 148 MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 149 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 150 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR REFERENCE LABORATORIES, BY COUNTRY, 2021-2026 (USD MILLION)
  • 10.5 OTHER END USERS
    • TABLE 151 MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 152 MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY REGION, 2021-2026 (USD MILLION)
    • TABLE 153 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 154 NORTH AMERICA: MULTIPLEX ASSAYS MARKET FOR OTHER END USERS, BY COUNTRY, 2021-2026 (USD MILLION)

11 MULTIPLEX ASSAYS MARKET, BY REGION

  • 11.1 INTRODUCTION
    • TABLE 155 MULTIPLEX ASSAYS MARKET, BY REGION, 2016-2020 (USD MILLION)
    • TABLE 156 MULTIPLEX ASSAYS MARKET, BY REGION, 2021-2026 (USD MILLION)
  • 11.2 NORTH AMERICA
    • FIGURE 22 NORTH AMERICA: MULTIPLEX ASSAYS MARKET SNAPSHOT
    • TABLE 157 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2016-2020 (USD MILLION)
    • TABLE 158 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY COUNTRY, 2021-2026 (USD MILLION)
    • TABLE 159 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 160 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 161 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 162 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 163 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 164 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • TABLE 165 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 166 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 167 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 168 NORTH AMERICA: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 11.2.1 US
    • TABLE 169 US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 170 US: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 171 US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 172 US: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 173 US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 174 US: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • TABLE 175 US: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 176 US: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 177 US: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 178 US: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
    • 11.2.2 CANADA
    • TABLE 179 CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 180 CANADA: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 181 CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 182 CANADA: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 183 CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 184 CANADA: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • TABLE 185 CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 186 CANADA: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 187 CANADA: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 188 CANADA: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 11.3 EUROPE
    • TABLE 189 EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 190 EUROPE: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 191 EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 192 EUROPE: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 193 EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 194 EUROPE: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • TABLE 195 EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 196 EUROPE: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 197 EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 198 EUROPE: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 11.4 ASIA PACIFIC
    • FIGURE 23 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET SNAPSHOT
    • TABLE 199 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 200 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 201 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 202 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 203 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 204 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • TABLE 205 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 206 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 207 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 208 ASIA PACIFIC: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)
  • 11.5 REST OF THE WORLD
    • TABLE 209 ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2016-2020 (USD MILLION)
    • TABLE 210 ROW: MULTIPLEX ASSAYS MARKET, BY PRODUCT & SERVICE, 2021-2026 (USD MILLION)
    • TABLE 211 ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2016-2020 (USD MILLION)
    • TABLE 212 ROW: MULTIPLEX ASSAYS MARKET, BY TYPE, 2021-2026 (USD MILLION)
    • TABLE 213 ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2016-2020 (USD MILLION)
    • TABLE 214 ROW: MULTIPLEX ASSAYS MARKET, BY TECHNOLOGY, 2021-2026 (USD MILLION)
    • TABLE 215 ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2016-2020 (USD MILLION)
    • TABLE 216 ROW: MULTIPLEX ASSAYS MARKET, BY APPLICATION, 2021-2026 (USD MILLION)
    • TABLE 217 ROW: MULTIPLEX ASSAYS MARKET, BY END USER, 2016-2020 (USD MILLION)
    • TABLE 218 ROW: MULTIPLEX ASSAYS MARKET, BY END USER, 2021-2026 (USD MILLION)

12 COMPETITIVE LANDSCAPE

  • 12.1 OVERVIEW
  • 12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN
    • 12.2.1 OVERVIEW OF THE STRATEGIES ADOPTED BY KEY PLAYERS IN THE MULTIPLEX ASSAYS MARKET, 2018 TO 2021
  • 12.3 MARKET RANKING ANALYSIS, 2020
    • FIGURE 24 MULTIPLEX MARKET SHARE ANALYSIS, 2020
    • TABLE 219 MULTIPLEX ASSAYS MARKET: DEGREE OF COMPETITION
  • 12.4 COMPANY EVALUATION QUADRANT (MAJOR PLAYERS)
    • 12.4.1 STARS
    • 12.4.2 PERVASIVE PLAYERS
    • 12.4.3 EMERGING LEADERS
    • 12.4.4 PARTICIPANTS
    • FIGURE 25 MULTIPLEX ASSAYS MARKET (GLOBAL): COMPANY EVALUATION QUADRANT, 2020
  • 12.5 COMPANY EVALUATION QUADRANT (SMES/STARTUPS)
    • 12.5.1 PROGRESSIVE COMPANIES
    • 12.5.2 STARTING BLOCKS
    • 12.5.3 RESPONSIVE COMPANIES
    • 12.5.4 DYNAMIC COMPANIES
    • FIGURE 26 MULTIPLEX ASSAYS MARKET: COMPANY EVALUATION QUADRANT FOR START-UPS/SMES, 2020
  • 12.6 COMPETITIVE SITUATION AND TRENDS
    • 12.6.1 PRODUCT LAUNCHES AND APPROVALS
    • TABLE 220 PRODUCT LAUNCHES AND APPROVALS, 2018-2021
    • 12.6.2 DEALS
    • TABLE 221 DEALS, 2018-2021
    • 12.6.3 OTHER DEVELOPMENTS
    • TABLE 222 OTHER DEVELOPMENTS, 2018-2021

13 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 13.1 ILLUMINA, INC.
    • TABLE 223 ILLUMINA, INC.: BUSINESS OVERVIEW
    • FIGURE 27 COMPANY SNAPSHOT: ILLUMINA, INC. (2020)
  • 13.2 LUMINEX CORPORATION
    • TABLE 224 LUMINEX CORPORATION: BUSINESS OVERVIEW
    • FIGURE 28 LUMINEX CORPORATION: COMPANY SNAPSHOT (2020)
  • 13.3 THERMO FISHER SCIENTIFIC INC.
    • TABLE 225 THERMO FISHER SCIENTIFIC INC.: BUSINESS OVERVIEW
    • FIGURE 29 COMPANY SNAPSHOT: THERMO FISHER SCIENTIFIC INC. (2020)
  • 13.4 BIO-RAD LABORATORIES, INC.
    • TABLE 226 BIO-RAD LABORATORIES, INC.: BUSINESS OVERVIEW
    • FIGURE 30 COMPANY SNAPSHOT: BIO-RAD LABORATORIES, INC. (2020)
  • 13.5 BECTON DICKINSON AND COMPANY
    • TABLE 227 BECTON, DICKINSON AND COMPANY.: BUSINESS OVERVIEW
    • FIGURE 31 COMPANY SNAPSHOT: BECTON, DICKINSON AND COMPANY (2020)
  • 13.6 QIAGEN N.V.
    • TABLE 228 QIAGEN N.V.: BUSINESS OVERVIEW
    • FIGURE 32 COMPANY SNAPSHOT: QIAGEN N.V. (2020)
  • 13.7 ABCAM PLC
    • TABLE 229 ABCAM PLC.: BUSINESS OVERVIEW
    • FIGURE 33 COMPANY SNAPSHOT: ABCAM PLC (2020)
  • 13.8 MERCK KGAA
    • TABLE 230 MERCK KGAA.: BUSINESS OVERVIEW
    • FIGURE 34 COMPANY SNAPSHOT: MERCK KGAA (2020)
  • 13.9 AGILENT TECHNOLOGIES INC.
    • TABLE 231 AGILENT TECHNOLOGIES, INC.: BUSINESS OVERVIEW
    • FIGURE 35 COMPANY SNAPSHOT: AGILENT TECHNOLOGIES, INC. (2020)
  • 13.10 QUANTERIX
    • TABLE 232 QUANTERIX.: BUSINESS OVERVIEW
    • FIGURE 36 COMPANY SNAPSHOT: QUANTERIX (2020)
  • 13.11 DIASORIN S.P.A.
    • TABLE 233 DIASORIN S.P.A.: BUSINESS OVERVIEW
    • FIGURE 37 COMPANY SNAPSHOT: DIASORIN S.P.A. (2020)
  • 13.12 BIO-TECHNE CORPORATION
    • TABLE 234 BIO-TECHNE CORPORATION: BUSINESS OVERVIEW
    • FIGURE 38 COMPANY SNAPSHOT: BIO-TECHNE CORPORATION (2020)
  • 13.13 MESO SCALE DIAGNOSTICS, LLC
    • TABLE 235 MESO SCALE DIAGNOSTICS, LLC: BUSINESS OVERVIEW
  • 13.14 RANDOX LABORATORIES LTD.
    • TABLE 236 RANDOX LABORATORIES LTD.: BUSINESS OVERVIEW
  • 13.15 OLINK
    • TABLE 237 OLINK: BUSINESS OVERVIEW
  • 13.16 OTHER PLAYERS
    • 13.16.1 SEEGENE INC.
    • TABLE 238 SEEGENE INC.: COMPANY OVERVIEW
    • 13.16.2 PROMEGA CORPORATION
    • TABLE 239 PROMEGA CORPORATION: COMPANY OVERVIEW
    • 13.16.3 SIEMENS HEALTHINEERS
    • TABLE 240 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
    • 13.16.4 PERKINELMER INC.
    • TABLE 241 PERKINELMER INC.: COMPANY OVERVIEW
    • 13.16.5 SHIMADZU CORPORATION
    • TABLE 242 SHIMADZU CORPORATION: COMPANY OVERVIEW
    • 13.16.6 ANTIGENIX AMERICA, INC.
    • TABLE 243 ANTIGENIX AMERICA, INC.: COMPANY OVERVIEW
    • 13.16.7 ENZO LIFE SCIENCES, INC.
    • TABLE 244 ENZO LIFE SCIENCES, INC: COMPANY OVERVIEW
    • 13.16.8 CAYMAN CHEMICAL LTD.
    • TABLE 245 CAYMAN CHEMICAL LTD.: COMPANY OVERVIEW
    • 13.16.9 BOSTER BIOLOGICAL TECHNOLOGY
    • TABLE 246 BOSTER BIOLOGICAL TECHNOLOGY: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

14 APPENDIX

  • 14.1 INSIGHTS OF INDUSTRY EXPERTS
  • 14.2 DISCUSSION GUIDE
  • 14.3 KNOWLEDGE STORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 14.4 AVAILABLE CUSTOMIZATIONS
  • 14.5 RELATED REPORTS
  • 14.6 AUTHOR DETAILS
Back to Top
전화 문의
F A Q